Related Experiment Videos
[Malignant or benign thyroid nodules: a diagnostic dilemma].
J Dadan1, J Łaszkiewicz, U Łebkowska
1I Klinika Chirurgii Ogólnej AM w Białymstoku.
Summary
Thyroid carcinomas often present with cystic or cystoid-solid lesions, detectable via ultrasonography. Negative fine needle aspiration biopsy results do not rule out malignancy, especially in nodular-cystic goiters.
Area of Science:
- Endocrinology
- Oncology
- Diagnostic Imaging
Background:
- Thyroid nodules are common, but distinguishing benign from malignant lesions requires accurate diagnostic methods.
- Cystic and cystoid-solid changes within thyroid nodules can complicate diagnosis.
- Preoperative assessment is crucial for effective thyroid cancer management.
Purpose of the Study:
- To determine the incidence of cystic and cystoid-solid lesions in thyroid carcinomas.
- To evaluate the diagnostic utility of ultrasonography (USG) and fine needle aspiration biopsy (FNAB) in these cases.
- To correlate preoperative findings with postoperative histopathological results.
Main Methods:
- Retrospective analysis of 661 surgically treated patients with thyroid disorders.
- Preoperative ultrasonographic examinations (USG) for lesion characterization.
- Fine needle aspiration biopsy (FNAB) for cytological evaluation.
- Postoperative histopathological examination for definitive diagnosis.
Main Results:
- Thyroid carcinoma was diagnosed in 46 patients (3.9%), with papillary carcinoma being most common (n=34).
- Preoperative USG identified cystic or cystoid-solid lesions in 39% (18/46) of carcinoma patients.
- FNAB yielded positive, negative, or suspect results in these 18 patients; malignancy was confirmed histopathologically.
- Malignant neoplasms were associated with cystic/cystoid-solid lesions in approximately 40% of cases.
Conclusions:
- Malignant thyroid neoplasms frequently exhibit cystic and cystoid-solid features.
- Multiple USG-guided FNABs may be necessary for adequate sampling.
- A negative FNAB result does not exclude thyroid carcinoma, particularly in nodular-cystic goiters.